Tag
drug
-
New Alzheimer’s drug draws attention from federal, independent groups
Liz Seegert, AHCJ’s topic leader on aging, contributed to this article. Federal policy experts and the influential Institute for Clinical…
-
New Alzheimer’s drug shows promise, but don’t celebrate yet
A recent announcement by drugmaker Eli Lilly that its drug donanemab slowed the progression of Alzheimer’s by nearly one-third is…
-
Biogen submits BLA for an Alzheimer’s drug with a controversial past
Could an Alzheimer’s drug finally be on the horizon? Possibly ― if the FDA agrees with data from several Biogen…
-
•
Alzheimer’s drug puts journalists’ judgment to test
It was the kind of news that had to be handled delicately, with a deft touch and a sense of…